The AIBL2 Research Project is supported by the Science & Industry Endowment Fund

The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) is a study to discover which biomarkers, cognitive characteristics, and health and lifestyle factors determine subsequent development of symptomatic Alzheimer’s Disease (AD).

• Launched on 14th November 2006, largest study of its kind in Australia.
• 4.5+year prospective longitudinal study of cognition.
• Large scale cohort study: 1000+ participants (minimum age 60 years).
• Patients with Alzheimer’s disease (AD), mild cognitive impairment (MCI) and healthy volunteers.
• Focus on early detection, towards lifestyle interventions.
• All data is collected at two centers (40% subjects from Perth in Western Australia, 60% from Melbourne, Victoria).
• A multidisciplinary research team is drawn from partner organisations in Perth, Sydney, Adelaide, Melbourne, Canberra and Brisbane.